Highlights D. Western Therapeutics Institute, Inc.

Equities

4576

JP3548740004

Market Closed - Japan Exchange Other stock markets 11:30:00 20/05/2024 am IST			5-day change	1st Jan Change
103 ^JPY	-7.21%		-1.90%	-26.95%

17/05	D. Western Therapeutics Institute, Inc. announced that it expects to receive ¥6.37 million in funding	CI
14/02	D. Western Therapeutics Institute, Inc. Provides Consolidated and Non Consolidated Earnings Guidance for the Full Year Ending December 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

D. Western Therapeutics Institute, Inc. Provides Consolidated and Non Consolidated Earnings Guidance for the Full Year Ending December 31, 2024	14/02	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2023	10/23/10	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2024	15/23/15	CI
D. Western Therapeutics Institute, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2023	14/23/14	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022	11/22/11	CI
D. Western Therapeutics Institute, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022	13/22/13	CI
D. Western Therapeutics Institute, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2022	14/22/14	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	12/21/12	CI
D. Western Therapeutics Institute, Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	11/21/11	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	11/21/11	CI
D. Western Therapeutics Institute, Inc. Reports Consolidated Financial Results for the First Quarter Ended March 31, 2021	13/21/13	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	13/21/13	CI
D. Western Therapeutics Institute, Inc. Reports Consolidated Financial Results for the Year Ended December 31, 2020	12/21/12	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2021	12/21/12	CI
D. Western Therapeutics Institute, Inc. Reports Consolidated Earnings Results for the Nine Months Ended September 30, 2020	13/20/13	CI
D. Western Therapeutics Institute, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2020	13/20/13	CI
D. Western Therapeutics Institute, Inc. Announces Consolidated Earnings Results for the Sis Months Ended June 30, 2020	14/20/14	CI
D. Western Therapeutics Institute, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2020	14/20/14	CI
D. Western Therapeutics Institute, Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2020; Provides Earnings Guidance for the Full Year Ending December 31, 2020	15/20/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights D. Western Therapeutics Institute, Inc.

Equities

4576

JP3548740004

Highlights

Filters